Skip to content

Multicenter Clinical Observation of Guilonghulou Coating Agent in Prevention and Treatment of Thrombosis of Autologous Arteriovenous Fistula in Hemodialysis Patients

Multicenter Clinical Observation of Guilonghulou Coating Agent in Prevention and Treatment of Thrombosis of Autologous Arteriovenous Fistula in Hemodialysis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002410
Enrollment
Unknown
Registered
2019-06-19
Start date
2019-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failure of autologous arteriovenous fistula

Interventions

Sponsors

the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria of uremia stage of chronic renal failure and have been treated with hemodialysis for 3 months or more; (2) Patients who have undergone autologous arteriovenous fistula surgery and met the maturity criteria of arteriovenous fistula in the first edition of Chinese consensus on vascular access for hemodialysis in 2014, and who have begun to puncture arteriovenous fistula for hemodialysis; (3) Blood flow of internal fistula can meet the criteria. The hemodialysis blood flow of patients was more than 250ml/min, the age of patients was between 18 and 80 years old, and the gender was not limited. (4) Informed consent to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Mental disorders, cognitive impairment, unable to cooperate with the study smoothly; (2) Coagulation dysfunction, with a significant bleeding tendency; (3) Autoimmune deficiency; (4) Allergic constitution or allergic to a variety of drugs; and (5) Poor compliance.

Design outcomes

Primary

MeasureTime frame
B-mode Ultrasound of Blood Vessels;Kidney function;

Secondary

MeasureTime frame
Liver function;Routine blood test;

Countries

China

Contacts

Public ContactJuan Xie

the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

477935578@qq.com+86 15985110288

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026